UF Innovate Insights Seminar: Intersection of Patent and Regulatory Strategies in Drug Development

UF Innovate | Pathways and UF CTSI Present April's Insights Seminar: Intersection of Patent and Regulatory Strategies in Drug Development

Taking a therapeutic product from research and development (R&D) to commercial approval is costly and requires an estimated two billion dollars in investment. To recoup and see a return on investment, drug developers look to various exclusivities in order to realize such returns. Lately, the role of patents and regulatory exclusivities in pricing drugs is in the news. How do drug developers use the patent and regulatory laws to price drugs and see a return on investment? How do these two exclusivity frameworks intersect along the drug development pathway even at the earliest stages?

In this virtual seminar, attorneys Drs. Jeff Hsi and Will Czaplyski will share their insights on the interplay of patent and regulatory frameworks on drug development and their experience working with universities as well as large and small biopharma companies.